Heterologous two-dose Ebola vaccine regimen in pregnant women in Rwanda: a randomized controlled phase 3 trial

Journal:

Nature Medicine

Published:

2025-09-08

DOI:

10.1038/s41591-025-03932-z

Affiliations:

7

Authors:

20

Go to article

Institutions	Authors	Share
Project San Francisco (PSF), RZHRG, Rwanda	7.000000	0.35
Janssen Vaccines and Prevention B.V., Netherlands	6.000000	0.30
Rwanda Zambia HIV Research Group (RZHRG), United States of America (USA)	3.000000	0.15
Woodruff Health Sciences Center (WHSC), Emory University, United States of America (USA)	1.000000	0.05
Janssen Pharmaceutica, Belgium	1.000000	0.05
IQVIA, United States of America (USA)	1.000000	0.05
Janssen Inc., Canada	1.000000	0.05

Interested in Medical Microbiology?